PRESCRIBING · PART D · 2024
Total Rx claims
2,567
Beneficiaries
—
Total drug cost
$6.6M
Distinct drugs
27
Brand share
36.5%
Top prescribed drugs
Spironolactone334 claims
Torsemide288 claims
Sacubitril/Valsartan275 claims
Empagliflozin225 claims
Potassium Chloride220 claims
QUALITY · MIPS · 2024
No data available for this provider in 2024.
CROSS-REFERENCE